JILIN PROVINCE HUINAN CHANGLONG BIO-PHARMACY COMPANY LIMITED Financials Jilin Province Huinan Changlong Bio-pharmacy Company Limited
Equities
8049
CNE100000130
Pharmaceuticals
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.57 HKD | -15.14% |
|
-12.78% | -4.27% |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 477.2 | 455.6 | 575.3 | 538.7 | 430.5 | 835.1 |
| Enterprise Value (EV) 1 | -275.1 | -405.9 | 292.1 | 238.8 | -618.9 | 257.5 |
| P/E ratio | 2.96 x | 3.15 x | 4.55 x | 3.76 x | 2.22 x | 5.63 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 0.74 x | 0.71 x | 0.92 x | 0.76 x | 0.51 x | 0.99 x |
| EV / Revenue | -0.42 x | -0.63 x | 0.47 x | 0.34 x | -0.74 x | 0.31 x |
| EV / EBITDA | -1.49 x | -2.36 x | 2.15 x | 1.42 x | -3.25 x | 1.38 x |
| EV / FCF | -2.34 x | -3.27 x | 8.53 x | 2.08 x | -4.57 x | 0.94 x |
| FCF Yield | -42.8% | -30.5% | 11.7% | 48.1% | -21.9% | 106% |
| Price to Book | 0.42 x | 0.37 x | 0.43 x | 0.37 x | 0.27 x | 0.56 x |
| Nbr of stocks (in thousands) | 560,250 | 560,250 | 560,250 | 560,250 | 560,250 | 560,250 |
| Reference price 2 | 0.8517 | 0.8132 | 1.027 | 0.9615 | 0.7684 | 1.491 |
| Announcement Date | 3/29/19 | 6/30/20 | 3/31/21 | 4/29/22 | 4/2/23 | 3/28/24 |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 647.7 | 645.9 | 622.2 | 705.5 | 841.6 | 841.5 |
| EBITDA 1 | 184.2 | 171.9 | 135.7 | 168.7 | 190.4 | 187.1 |
| EBIT 1 | 164.9 | 151.7 | 114.4 | 140.6 | 158 | 160.6 |
| Operating Margin | 25.46% | 23.49% | 18.39% | 19.93% | 18.77% | 19.09% |
| Earnings before Tax (EBT) 1 | 186.3 | 175.3 | 150 | 177.3 | 197.3 | 198.3 |
| Net income 1 | 161.2 | 144.7 | 126.6 | 143.3 | 193.6 | 148.2 |
| Net margin | 24.89% | 22.41% | 20.34% | 20.31% | 23% | 17.61% |
| EPS 2 | 0.2878 | 0.2583 | 0.2259 | 0.2557 | 0.3455 | 0.2645 |
| Free Cash Flow 1 | 117.8 | 124 | 34.23 | 114.8 | 135.5 | 273.1 |
| FCF margin | 18.19% | 19.2% | 5.5% | 16.27% | 16.1% | 32.45% |
| FCF Conversion (EBITDA) | 63.95% | 72.12% | 25.23% | 68.04% | 71.14% | 145.97% |
| FCF Conversion (Net income) | 73.07% | 85.67% | 27.05% | 80.12% | 69.99% | 184.26% |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 3/29/19 | 6/30/20 | 3/31/21 | 4/29/22 | 4/2/23 | 3/28/24 |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 752 | 862 | 283 | 300 | 1,049 | 578 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | 118 | 124 | 34.2 | 115 | 135 | 273 |
| ROE (net income / shareholders' equity) | 15% | 12.2% | 9.8% | 10.2% | 12.6% | 9.58% |
| ROA (Net income/ Total Assets) | 7.38% | 5.88% | 4.12% | 4.53% | 4.44% | 4.28% |
| Assets 1 | 2,185 | 2,463 | 3,076 | 3,160 | 4,357 | 3,463 |
| Book Value Per Share 2 | 2.020 | 2.210 | 2.400 | 2.590 | 2.880 | 2.640 |
| Cash Flow per Share 2 | 0.2800 | 0.2500 | 0.0500 | 0.1000 | 0.2000 | 0.6300 |
| Capex 1 | 33.6 | 17 | 98.8 | 92.8 | 11.3 | 31.8 |
| Capex / Sales | 5.18% | 2.63% | 15.87% | 13.16% | 1.34% | 3.78% |
| Announcement Date | 3/29/19 | 6/30/20 | 3/31/21 | 4/29/22 | 4/2/23 | 3/28/24 |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -4.27% | 112M | |
| -4.66% | 86.13B | |
| +1.32% | 39.82B | |
| -19.27% | 30.42B | |
| +57.86% | 25.23B | |
| -16.09% | 15.36B | |
| -9.14% | 11.95B | |
| -17.69% | 11.6B | |
| -43.00% | 11.51B | |
| +5.24% | 8.71B |
- Stock Market
- Equities
- 8049 Stock
- Financials Jilin Province Huinan Changlong Bio-pharmacy Company Limited
